Avid Bioservices, Inc. Common Stock
CDMO
CDMO was delisted on the 4th of February, 2025.
187 hedge funds and large institutions have $933M invested in Avid Bioservices, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 59 increasing their positions, 68 reducing their positions, and 24 closing their positions.
18% more call options, than puts
Call options by funds: $466K | Put options by funds: $396K
8% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 24
3% less funds holding
Funds holding: 193 → 187 (-6)
13% less repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 68
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
26% less capital invested
Capital invested by funds: $1.26B → $933M (-$328M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
+$9.03M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$8.66M |
| 3 |
AC
AltraVue Capital
Bellevue,
Washington
|
+$7.13M |
| 4 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$4.36M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$3.98M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$23.8M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$5.85M |
| 3 |
CM
Castleark Management
Chicago,
Illinois
|
-$3.99M |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
-$3.14M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$2.88M |
CDMO Hedge Fund Activity: Q2 2022 in Review
187 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q2 2022, worth a combined $933M — down 26% from $1.26B a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of CDMO and 22 opened new positions — a net loss of 2 holders — while 68 trimmed existing stakes and 59 added.
The largest buyer was Jennison Associates, adding an estimated $9.03M. The largest seller was Fidelity Investments, cutting an estimated $23.8M.
- 187 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q2 2022, down from 193 in Q1 2022.
- Funds reported $933M of Avid Bioservices, Inc. Common Stock stock for Q2 2022, down 26% quarter-over-quarter.
- 22 funds opened new Avid Bioservices, Inc. Common Stock positions in Q2 2022 and 24 closed out, a net change of -2 holders.
- The largest Avid Bioservices, Inc. Common Stock buyer in Q2 2022 was Jennison Associates, an estimated $9.03M added.
- The largest Avid Bioservices, Inc. Common Stock seller in Q2 2022 was Fidelity Investments, an estimated $23.8M sold.
Based on aggregated 13F filings for Q2 2022.